L37PA
L37PA has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jul 26, 2023: “Aging-Related Accumulation of Truncated Oxidized Phospholipids Augments Infectious Lung Injury and Endothelial Dysfunction via Cluster of Differentiation 36-Dependent Mechanism”.
1 paper studies it1 findingUpdated
- 1 lab in 1 country
- Funders: National Heart, Lung, and Blood Institute and 1 more
- Animals1
What did studies of L37PA find?
1Studies of L37PA measured 1 outcome; the most studied are vascular leak (1 study).
Vascular leak
downin mice1
1 study
Vascular leak
downin mice1
L37PA decreases vascular leak in mice.
“L37pA peptide targeting CD36 receptor attenuated Tr-OxPL-induced endothelial cell permeability in young and old mLEC and ameliorated KOdiA-PC-induced vascular leak and lung inflammation in vivo.”
AnimalsKOdiA-PC-inducedlung
Cells